PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
28-Jun-2023 RAIR Health and Royal Cornwall Hospitals NHS Trust Sign Services and Data License Agreement RAIR HEALTH LIMITED
28-Jun-2023 Innovation Summit celebrates decade of growth at Discovery Park Discovery Park
28-Jun-2023 Key visit could boost North East England health tech in the wake of inaugural festival EY
28-Jun-2023 MOB-015 is recommended for approval in EU Moberg Pharma AB
28-Jun-2023 ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research ExeVir Bio
28-Jun-2023 More than 1 in 10 mental health jobs in the NHS are currently vacant despite a sharp rise in people seeking help NHS
28-Jun-2023 Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active DopaVision
27-Jun-2023 HUTCHMED to Announce 2023 Half-Year Financial Results HUTCHMED
27-Jun-2023 Cyntegrity’s MyRBQM Portal, an AI-Supported Clinical Trial Risk Management Solution, is Now Available in the Microsoft Azure Marketplace Cyntegrity
27-Jun-2023 GPCR passes Technology Evaluation process for listing on KOSDAQ GPCR Therapeutics
27-Jun-2023 Sobi completes acquisition of CTI BioPharma Corp. CTI BioPharma Corp.
27-Jun-2023 Commercial trial to treat major depressive disorder with psychedelic drugs given green light by MHRA Clerkenwell Health
27-Jun-2023 DIPHARMA AND LOGIXX PHARMA ANNOUNCE GRANTING OF MARKETING AUTHORISATION APPROVAL FOR GENERIC SAPROPTERIN IN UNITED KINGDOM Dipharma SA (“Dipharma”) and LogixX Pharma (“LogixX”)
27-Jun-2023 Taking higher-than-recommended doses of vitamin D for five years reduced the risk of atrial fibrillation University of Eastern Finland
27-Jun-2023 Shareholders Approve all Board Proposals at Today’s Annual General Meeting Santhera Pharmaceuticals
27-Jun-2023 Researchers highlight flaws in COVID-19 weather studies and call for improved publishing practices The University of Manchester
27-Jun-2023 Immodulon Further Strengthens Leadership Team with the Appointments of Richard Couch as Chief Technology Officer and Owen Vaughan as Chief Regulatory Officer Immodulon Therapeutics Ltd
27-Jun-2023 Astraveus raises €16.5 Million Series Seed round to advance the development of its automated, microfluidic Cell and Gene Therapy manufacturing platform Astraveus SAS
27-Jun-2023 Cresset Creates New Vice President Role to Lead their Discovery CRO Business Cresset
27-Jun-2023 Bloomsbury Genetic Therapies Completes Successful Scientific Advice Meeting with the MHRA regarding its BGT-INAD Program Bloomsbury Genetic Therapies Limited